申请人:The Procter & Gamble Company
公开号:US20030130271A1
公开(公告)日:2003-07-10
The invention provides compounds of formula
1
as described in the claims, or an optical isomer, diastereomer or enantiomer thereof, or a pharmaceutically-acceptable salt, or biohydrolyzable amide, ester, or imide thereof are useful as inhibitors of metalloproteases.
Also disclosed are pharmaceutical compositions and methods of treating diseases, disorders and conditions characterized by metalloprotease activity using these compounds or the pharmaceutical compositions containing them.
本发明提供了式 1 的化合物
1
或其光学异构体、非对映异构体或对映体,或其药学上可接受的盐,或其生物可水解的酰胺、酯或亚胺,可作为金属蛋白酶的抑制剂。
此外,还公开了使用这些化合物或含有这些化合物的药物组合物治疗以金属蛋白酶活性为特征的疾病、失调和病症的药物组合物和方法。